Table 1.
Country profile and communicable and non-communicable disease burden in Sierra Leone.
| Variable | Result | Source |
|---|---|---|
| Population characteristics | Total population: 7,092,113 | 2015 SL population census 17 |
| Population under 15 years: 42% | ||
| Annual population growth rate: 3.2% | ||
| Percentage of women aged 15–49 years: 51.0% | ||
| Total population of women aged 15–49: 1,835, 328 | ||
| Economic status | UN Human Development Index: 184 out of 188 | SMTDP 2019–2023 18 ; DHS 2019 19 |
| Poverty level: 57% | ||
| Health status | Total number of functional health facilities: 1512 (67 Hospitals, 153 Clinics, 251 Community Health Centers, 423 Community Health Posts and 618 Maternal and Child Health Posts). | SLMTDP 2019–2023 18 ; MICS 2017; DHS 2019 19 |
| Maternal mortality rate: 717 per 100,000 live births | ||
| Infant mortality rate: 75 per 1000 live births | ||
| Life expectancy at birth in 2017: 52.2 years | ||
| Prevalence of underweight (weight/age) among children 6–59 months (2SD): 11.7% | ||
| HIV | The national prevalence of HIV among persons aged 15–49 years: 1.7% | DHS 2019 19 ; UNAIDS 2019 16 ; Lakoh et al. 20 ; Yendewa et al. 21 ; Lakoh et al. 22 ; UNAIDS 2018 15 |
| Total number of people living with HIV: 78,667 | ||
| Number of AIDS patients receiving ARVS: 32,468 | ||
| Prevalence of advanced HIV disease: 69.6% | ||
| Prevalence of late-stage HIV diagnosis: 75.4% | ||
| HIV prevalence in TB patients: 32.0% | ||
| AIDS-related deaths: 2700 | ||
| TB | National TB incidence rate: 295 per 100,000 | Global TB Report 2020 23 |
| Total TB cases: 23,000 | ||
| Number of notified TB cases in 2019: 17,144 | ||
| % of TB cases co-infected with HIV: 12.6% | ||
| Total TB survivors: 19,920 | ||
| Pulmonary TB survivors: 18,526 | ||
| Asthma, COPD and cystic fibrosis | Asthma rate in adults: 4.59% | To et al. 24 |
| Asthma number in adults: 200, 147 | Hammond et al. | |
| COPD prevalence GOLD stages II–IV: 3.20% | ||
| COPD admissions to hospital per year: 27,704 (assumes 10.5% admissions per year) | ||
| Cystic fibrosis: 0 | ||
| Malignancies | Number of lung cancer deaths per 100,000 population: 127 | Winkler et al. 25 ; ICD-10 C92.0 |
| AML population frequency×/100,000: 2.5 | ||
| AML patients per year: 191 | ||
| Transplant recipient | Allogenic hematologic stem cell transplant: 0 | |
| Renal, lung, heart, and liver transplants: 0 |
AIDS, autoimmune deficiency syndrome; AML, acute myeloid leukemia; ARVS; antiretroviral treatment; COPD, chronic obstructive pulmonary disease; GOLD, The Global Initiative for Chronic Obstructive Lung Disease; HIV, human immunodeficiency virus; SD, standard deviation; SL, Sierra Leone; TB, tuberculosis; UN, United Nations.